At µNEURO, we bring together complementary expertise, technologies, and model systems to strengthen translational neuroscience research. Through close collaboration between fundamental researchers, imaging experts, and clinicians, we develop state-of-the-art and standardized research pipelines that can be applied across multiple neurological diseases and experimental platforms.
Our multidisciplinary approach is organized around three interconnected scientific pillars. Together, these efforts aim to generate new insights into nervous system function and dysfunction, while advancing diagnosis, prognosis, and treatment in key disease areas, including dementia, Huntington’s disease, and neuromuscular disorders.
Consolidate an effective translational platform for bench-to-bedside research
μ±··¡±«¸é°¿ integrates complementary technologies, experimental model systems, and clinical research to bridge the gap between fundamental discoveries and patient care. By combining insights from cellular, animal, and human studies, we uncover disease mechanisms, identify diagnostic and prognostic biomarkers, and evaluate novel therapeutic strategies.
This bench-to-bedside approach not only improves our understanding of neurological disorders but also ensures that clinical observations continuously inform and inspire new research directions.​
Establish a toolbox for integrated multidimensional analysis of the nervous system
μ±··¡±«¸é°¿ combines expertise in imaging across scales (from microscopy to MRI, PET, SPECT, and CT) to build an integrated view of the nervous system in health and disease. By linking multimodal imaging with measures of brain function, genetic information, fluid biomarkers, and spatial omics, we generate comprehensive datasets that reveal biological mechanisms and support the discovery of predictive and prognostic biomarkers.
Innovative tools for acquisition and processing of different imaging techniques
μ±··¡±«¸é°¿ develops and applies next-generation imaging technologies and analytical methods across microscopy, MRI, PET/SPECT, and CT. By bringing together technology developers, imaging experts, and clinicians, we accelerate the translation of novel methodologies, biomarkers, and radiotracers from preclinical research to human studies. Through our linked core facilities, these innovations can also support research beyond neuroscience.